Womens Health Diagnostics Market 2027 by Type, Application | The Insight Partners

Womens Health Diagnostics Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Diagnostic Devices, Diagnostic Tests); Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, Others)

Report Code: TIPRE00009203 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Womens health refers to the health of women, which differs from that of men in many unique ways. Womens health is an example of population health, where the World Health Organization defines health as "a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity".

MARKET DYNAMICS

The womens health diagnostics market is growing due to the increasing prevalence of osteoarthritis, ovarian cancer, breast cancer and cervical cancer. Moreover, increasing cases has resulted in increased sales test kits for home usage that is expected to benefit the growth of the market in the forecast period.

MARKET SCOPE

The "Womens Health Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in womens health diagnostics market with detailed market segmentation by type, application and geography. The womens health diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in womens health diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The womens health diagnostics market is segmented on the basis of type, and application. Based on type the market is segmented as diagnostic devices and diagnostic tests. On the basis of diagnostic devices the market is categorized as biopsy devices, imaging and monitoring system and others. On the basis of diagnostic tests the market is categorized as breast cancer testing, Pap smear (PAP) and HPV test, pregnancy testing and ovulation testing and others. On the basis of application the market is categorized as breast cancer, infectious disease testing, osteoporosis testing, pregnancy and fertility testing, sexually transmitted disease testing and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in womens health diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The womens health diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting womens health diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the womens health diagnostics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in womens health diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in womens health diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for in womens health diagnostics market in the global market. Below mentioned is the list of few companies engaged in the womens health diagnostics market.

The report also includes the profiles of key in womens health diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Abbott Laboratories
- Becton Dickinson and Company
- bioMérieux SA
- Cardinal Health
- F. Hoffmann-La Roche AG
- GE Healthcare
- Hologic, Inc.
- Koninklijke Philips N.V.
- Quest Diagnostics Inc.
- Siemens AG

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Womens Health Diagnostics Market - By Type
1.3.2 Womens Health Diagnostics Market - By Application
1.3.3 Womens Health Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. WOMENS HEALTH DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. WOMENS HEALTH DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. WOMENS HEALTH DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. WOMENS HEALTH DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. WOMENS HEALTH DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. WOMENS HEALTH DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DIAGNOSTIC DEVICES
7.3.1. Overview
7.3.2. Diagnostic Devices Market Forecast and Analysis
7.3.3. Biopsy Devices Market
7.3.3.1. Overview
7.3.3.2. Biopsy Devices Market Forecast and Analysis
7.3.4. Imaging and Monitoring System Market
7.3.4.1. Overview
7.3.4.2. Imaging and Monitoring System Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. DIAGNOSTIC TESTS
7.4.1. Overview
7.4.2. Diagnostic Tests Market Forecast and Analysis
7.4.3. Breast Cancer Testing Market
7.4.3.1. Overview
7.4.3.2. Breast Cancer Testing Market Forecast and Analysis
7.4.4. PAP Smear (PAP) and HPV Test Market
7.4.4.1. Overview
7.4.4.2. PAP Smear (PAP) and HPV Test Market Forecast and Analysis
7.4.5. Pregnancy Testing and Ovulation Testing Market
7.4.5.1. Overview
7.4.5.2. Pregnancy Testing and Ovulation Testing Market Forecast and Analysis
7.4.6. Others Market
7.4.6.1. Overview
7.4.6.2. Others Market Forecast and Analysis
8. WOMENS HEALTH DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BREAST CANCER
8.3.1. Overview
8.3.2. Breast Cancer Market Forecast and Analysis
8.4. INFECTIOUS DISEASE TESTING
8.4.1. Overview
8.4.2. Infectious Disease Testing Market Forecast and Analysis
8.5. OSTEOPOROSIS TESTING
8.5.1. Overview
8.5.2. Osteoporosis Testing Market Forecast and Analysis
8.6. PREGNANCY AND FERTILITY TESTING
8.6.1. Overview
8.6.2. Pregnancy and Fertility Testing Market Forecast and Analysis
8.7. SEXUALLY TRANSMITTED DISEASE TESTING
8.7.1. Overview
8.7.2. Sexually Transmitted Disease Testing Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. WOMENS HEALTH DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Womens Health Diagnostics Market Overview
9.1.2 North America Womens Health Diagnostics Market Forecasts and Analysis
9.1.3 North America Womens Health Diagnostics Market Forecasts and Analysis - By Type
9.1.4 North America Womens Health Diagnostics Market Forecasts and Analysis - By Application
9.1.5 North America Womens Health Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Womens Health Diagnostics Market
9.1.5.1.1 United States Womens Health Diagnostics Market by Type
9.1.5.1.2 United States Womens Health Diagnostics Market by Application
9.1.5.2 Canada Womens Health Diagnostics Market
9.1.5.2.1 Canada Womens Health Diagnostics Market by Type
9.1.5.2.2 Canada Womens Health Diagnostics Market by Application
9.1.5.3 Mexico Womens Health Diagnostics Market
9.1.5.3.1 Mexico Womens Health Diagnostics Market by Type
9.1.5.3.2 Mexico Womens Health Diagnostics Market by Application
9.2. EUROPE
9.2.1 Europe Womens Health Diagnostics Market Overview
9.2.2 Europe Womens Health Diagnostics Market Forecasts and Analysis
9.2.3 Europe Womens Health Diagnostics Market Forecasts and Analysis - By Type
9.2.4 Europe Womens Health Diagnostics Market Forecasts and Analysis - By Application
9.2.5 Europe Womens Health Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Womens Health Diagnostics Market
9.2.5.1.1 Germany Womens Health Diagnostics Market by Type
9.2.5.1.2 Germany Womens Health Diagnostics Market by Application
9.2.5.2 France Womens Health Diagnostics Market
9.2.5.2.1 France Womens Health Diagnostics Market by Type
9.2.5.2.2 France Womens Health Diagnostics Market by Application
9.2.5.3 Italy Womens Health Diagnostics Market
9.2.5.3.1 Italy Womens Health Diagnostics Market by Type
9.2.5.3.2 Italy Womens Health Diagnostics Market by Application
9.2.5.4 Spain Womens Health Diagnostics Market
9.2.5.4.1 Spain Womens Health Diagnostics Market by Type
9.2.5.4.2 Spain Womens Health Diagnostics Market by Application
9.2.5.5 United Kingdom Womens Health Diagnostics Market
9.2.5.5.1 United Kingdom Womens Health Diagnostics Market by Type
9.2.5.5.2 United Kingdom Womens Health Diagnostics Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Womens Health Diagnostics Market Overview
9.3.2 Asia-Pacific Womens Health Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Womens Health Diagnostics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Womens Health Diagnostics Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Womens Health Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Womens Health Diagnostics Market
9.3.5.1.1 Australia Womens Health Diagnostics Market by Type
9.3.5.1.2 Australia Womens Health Diagnostics Market by Application
9.3.5.2 China Womens Health Diagnostics Market
9.3.5.2.1 China Womens Health Diagnostics Market by Type
9.3.5.2.2 China Womens Health Diagnostics Market by Application
9.3.5.3 India Womens Health Diagnostics Market
9.3.5.3.1 India Womens Health Diagnostics Market by Type
9.3.5.3.2 India Womens Health Diagnostics Market by Application
9.3.5.4 Japan Womens Health Diagnostics Market
9.3.5.4.1 Japan Womens Health Diagnostics Market by Type
9.3.5.4.2 Japan Womens Health Diagnostics Market by Application
9.3.5.5 South Korea Womens Health Diagnostics Market
9.3.5.5.1 South Korea Womens Health Diagnostics Market by Type
9.3.5.5.2 South Korea Womens Health Diagnostics Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Womens Health Diagnostics Market Overview
9.4.2 Middle East and Africa Womens Health Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Womens Health Diagnostics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Womens Health Diagnostics Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Womens Health Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Womens Health Diagnostics Market
9.4.5.1.1 South Africa Womens Health Diagnostics Market by Type
9.4.5.1.2 South Africa Womens Health Diagnostics Market by Application
9.4.5.2 Saudi Arabia Womens Health Diagnostics Market
9.4.5.2.1 Saudi Arabia Womens Health Diagnostics Market by Type
9.4.5.2.2 Saudi Arabia Womens Health Diagnostics Market by Application
9.4.5.3 U.A.E Womens Health Diagnostics Market
9.4.5.3.1 U.A.E Womens Health Diagnostics Market by Type
9.4.5.3.2 U.A.E Womens Health Diagnostics Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Womens Health Diagnostics Market Overview
9.5.2 South and Central America Womens Health Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Womens Health Diagnostics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Womens Health Diagnostics Market Forecasts and Analysis - By Application
9.5.5 South and Central America Womens Health Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Womens Health Diagnostics Market
9.5.5.1.1 Brazil Womens Health Diagnostics Market by Type
9.5.5.1.2 Brazil Womens Health Diagnostics Market by Application
9.5.5.2 Argentina Womens Health Diagnostics Market
9.5.5.2.1 Argentina Womens Health Diagnostics Market by Type
9.5.5.2.2 Argentina Womens Health Diagnostics Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. WOMENS HEALTH DIAGNOSTICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BECTON DICKINSON AND COMPANY
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOMéRIEUX SA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CARDINAL HEALTH
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. F. HOFFMANN-LA ROCHE AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GE HEALTHCARE
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HOLOGIC, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. KONINKLIJKE PHILIPS N.V.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. QUEST DIAGNOSTICS INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SIEMENS AG
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Becton Dickinson and Company
3. bioMérieux SA
4. Cardinal Health
5. F. Hoffmann-La Roche AG
6. GE Healthcare
7. Hologic, Inc.
8. Koninklijke Philips N.V.
9. Quest Diagnostics Inc.
10. Siemens AG
TIPRE00009203
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking